Zydolab - Institute of Cytology and Immune Cytochemistry
Dr. med. Hilal ziot
To investigate the effect of coughing as an intervention to reduce pain in colposcopy guided biopsy.
Cervical Cancer
Cervical Dysplasia
Colposcopy
Pain Sensation
Cervical Biopsy
Coughing at the time of biopsy
NA
Colposcopy is a frequently practiced examination and Colposcopy guided biopsy causes pain. A few trials Investigated whether medical interventions such as the application of lidocaine led to reduced pain perception with inconsistent results. Only one trial compared coughing versus no coughing at the moment of biopsy. Although the results of this study did not lead to a significant difference between the two study arms, coughing seems to positively affect pain perception. Since the patients are, in the best case, their own controls when it comes to subjective parameters such as pain perception, we prefer a cross-over rather than a parallel group design. Based on the descriptive variables for pain during biopsy with and without cough determined in the pilot study, a case estimate for a prospective randomized cross-over study will be carried out. Since two biopsies are usually taken from the cervix in daily practice, the now planned pilot study in a cross-over design envisages the following two study arms: 1. Group I: Patients cough during the first biopsy, they do not cough during the second biopsy 2. Group II: Patients cough during the second biopsy, they do not cough during the first biopsy The primary Outcome measure is the difference in the patients' perception of pain during the first and second biopsy on the cervix (ectocervix), measured using an 11-part numerical analogue scale (11-item NAS).
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 30 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | Pain Reduction by Forced Coughing During Colposcopy Guided Cervical Biopsies: a Randomized Controlled Pilot Study |
Actual Study Start Date : | 2024-01-02 |
Estimated Primary Completion Date : | 2024-04-30 |
Estimated Study Completion Date : | 2024-05-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 80 Years |
Sexes Eligible for Study: | FEMALE |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Zydolab - Institute of Cytology and Immune Cytochemistry
Dortmund, NRW, Germany, 44137